These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27712768)

  • 1. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Steinke JW; Payne SC; Borish L
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of aspirin-exacerbated respiratory disease and reactions.
    Laidlaw TM; Boyce JA
    Immunol Allergy Clin North Am; 2013 May; 33(2):195-210. PubMed ID: 23639708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease.
    Cahill KN; Laidlaw TM
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):681-691. PubMed ID: 27712763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
    Cousins K; Chen CC; Sehanobish E; Jerschow E
    Adv Pharmacol; 2023; 97():423-444. PubMed ID: 37236766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin-Exacerbated Respiratory Disease.
    Walgama ES; Hwang PH
    Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
    Wang XS; Wu AY; Leung PS; Lau HY
    Allergy; 2007 Jun; 62(6):620-7. PubMed ID: 17508965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease.
    Crofford LJ
    Arthritis Res Ther; 2003; 5(1):25-7. PubMed ID: 12716444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.
    Dahlin A; Weiss ST
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):765-789. PubMed ID: 27712769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of aspirin sensitivity.
    Picado C
    Curr Allergy Asthma Rep; 2006 May; 6(3):198-202. PubMed ID: 16579869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.
    Laidlaw TM; Cutler AJ; Kidder MS; Liu T; Cardet JC; Chhay H; Feng C; Boyce JA
    J Allergy Clin Immunol; 2014 Jun; 133(6):1692-701.e3. PubMed ID: 24486071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease.
    Luskin K; Thakrar H; White A
    Immunol Allergy Clin North Am; 2020 May; 40(2):329-343. PubMed ID: 32278455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of aspirin-sensitive respiratory disease--a two-compartment model.
    Farooque S; Lee T
    Int Arch Allergy Immunol; 2007; 142(1):59-63. PubMed ID: 17016058
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.
    Stevens WW; Schleimer RP
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):669-680. PubMed ID: 27712762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.